ACM
AKBA icon

Aquatic Capital Management’s Akebia Therapeutics AKBA Stock Holding History

Aquatic Capital Management’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-294,285
Closed -$474K – 1325
2025
Q4 		$474K Sell
294,285
-212,624
-42% -$445K 0.01% 755
2025
Q3 		$1.38M Buy
506,909
+458,276
+942% +$1.52M 0.03% 581
2025
Q2 		$177K Buy
+48,633
New +$134K ﹤0.01% 1034
2025
Q1 		– Sell
-24,998
Closed -$47.5K – 1236
2024
Q4 		$47.5K Buy
+24,998
New +$43.4K ﹤0.01% 1169
2022
Q2 		– Sell
-4,700
Closed -$3K – 1163
2022
Q1 		$3K Buy
+4,700
New +$10.1K ﹤0.01% 892

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Aquatic Capital Management's AKBA Position: Q1 2026 in Review

Aquatic Capital Management sold out of Akebia Therapeutics (AKBA) in Q1 2026, closing a stake of 294,285 shares — an estimated $474K sold.

Aquatic Capital Management first reported a position in AKBA in Q1 2022 and held it in 5 quarters. The position peaked at $1.38M in Q3 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Aquatic Capital Management reported no remaining Akebia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 294,285 Akebia Therapeutics shares in Q1 2026, an estimated $474K.
  • Aquatic Capital Management first reported a position in Akebia Therapeutics in Q1 2022 and held it in 5 quarters.
  • Aquatic Capital Management's Akebia Therapeutics position peaked at $1.38M in Q3 2025.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.